iSpecimen (ISPC) Equity Average (2020 - 2026)

iSpecimen (ISPC) has reported Equity Average for 7 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Average fell 21.63% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 21.63% YoY), while the FY2025 annual figure was $3.2 million, down 50.97% from the prior year.
• Equity Average came in at $2.0 million for Q1 2026 at iSpecimen, down from $3.1 million in the prior quarter.
• The five-year high for Equity Average was $28.7 million in Q1 2022, with the low at $1.1 million in Q2 2025.
• Average Equity Average over 5 years is $11.5 million, with a median of $8.3 million recorded in 2024.
• Across the five-year window, Equity Average jumped 357.86% in 2022 and slumped 82.25% in 2025, its largest moves.
• Year by year, Equity Average stood at $21.4 million in 2022, then tumbled by 47.47% to $11.2 million in 2023, then plunged by 64.25% to $4.0 million in 2024, then fell by 23.23% to $3.1 million in 2025, then plunged by 36.66% to $2.0 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $2.0 million, $3.1 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.